Home Patent Forecast® Sectors Log In   Sign Up   Support   Contact  
Why Patent Forecast® What's Included Patent Forecast® Sectors Free Trial Pricing News Feed Subscribe Menu
Enjoy your FREE PREVIEW which shows only 2018 data and 25 documents. For full access, subscribe at any time.         Subscribe

AI Biotech / Diagnostics

Read More News and Insights

PhysIQ helps take on COVID-19

AI Biotech / Diagnostics Patent Forecast®

March 26, 2020

The Food and Drug Administration (FDA) has sanctioned labeling for physIQ's continuous remote monitoring system, pinpointIQ, for use with the COVID-19 pandemic. The labeling includes the use of the physIQ's multivariate change index (MCI). The remote monitoring system will provide continuous remote monitoring for confirmed or suspected COVID-19 patients or high-risk patients such as those with heart failure or hypertension. The system will passively collect wearable sensor data and apply advanced analytics to help health care facilities and lower the risk of exposure for patients and health care providers. 

With 12 documents in the AI Biotech/Diagnostics sector (4 documents directed towards "multivariate residual-based health index for human health monitoring"), physIQ shows dedication to enabling proactive care delivery models through personalized physiology analytics. Hopefully, the data and analysis provided from physIQ's platform will offer healthcare providers with an improved understanding of the COVID-19 pandemic.

Human Skeleton, Human Body, Anatomy

Relevant Patent Documents

Application 20180325460  

Article Source Link

www.businesswire.com


Read more like this in News This Week!   or   Share this link with your connections!